SCHEMBL2335294

SCHEMBL2335294

FC(F)(F)c1cc(Br)nc2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.64
ACP1 P24666 2/20 0.43
C1R P00736 1/20 0.42
AR P10275 2/20 0.42
ELANE P08246 1/20 0.41
PKM P14618 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2D6 P10635 3/20 0.41
CLK4 Q9HAZ1 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
RECQL P46063 1/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ESR1 P03372 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25118744 0.81 ATM (0.46) BACE1ELANECYP1A2ALDH1A1GAA
SCHEMBL3300391 0.79 BACE1 (0.66) BACE1ACP1C1RCYP1A2ALDH1A1
SCHEMBL30449773 0.78 BACE1 (0.64) BACE1ACP1C1RARELANE
SCHEMBL3375200 0.78 BACE1 (0.64) BACE1ACP1C1RELANEPKM
SCHEMBL30901286 0.78 BACE1 (0.64) BACE1ACP1C1RELANEPKM
SCHEMBL895250 0.78 BACE1 (0.64) BACE1ACP1C1RARELANE
SCHEMBL19117639 0.78 BACE1 (0.64) BACE1ACP1CYP1A2CYP2D6CLK4
SCHEMBL4116547 0.78 BACE1 (1.00) BACE1ACP1C1RCYP1A2ALDH1A1
SCHEMBL26090480 0.78 BACE1 (0.46) BACE1ACP1C1RARELANE
SCHEMBL13763620 0.77 BACE1 (0.58) BACE1ACP1CYP1A2CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9331290-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-05-03 US disclosed
US-9331290-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-05-03 US disclosed
US-20130112920-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112920-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
WO-2012007086-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed
US-20110309304-A1 LUMINESCENT SILVER COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-22 US disclosed
US-20110309304-A1 LUMINESCENT SILVER COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-22 US disclosed
US-20110309304-A1 LUMINESCENT SILVER COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-22 US disclosed
CN-102227437-A Luminescent silver complexes SUMITOMO CHEMICAL CO 2011-10-26 CN disclosed
EP-2360162-A1 LUMINESCENT SILVER COMPLEXES Sumitomo Chemical Company, Limited (JP) 2011-08-24 EP disclosed
EP-2360162-A1 LUMINESCENT SILVER COMPLEXES Sumitomo Chemical Company, Limited (JP) 2011-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110309304-A1 LUMINESCENT SILVER COMPLEX SOD1, AS3MT, GLO1 BACE1 4083/4885ACP1 719/4885C1R 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.